APA (7th ed.) Citation

De Marco, G., Helliwell, P., McGonagle, D., Emery, P., Coates, L., Hensor, E., & Marzo-Ortega, H. (2017). The GOLMePsA study protocol: An investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes. BioMed Central.

Chicago Style (17th ed.) Citation

De Marco, G., P. Helliwell, D. McGonagle, P. Emery, L. Coates, E. Hensor, and H. Marzo-Ortega. The GOLMePsA Study Protocol: An Investigator-initiated, Double-blind, Parallel-group, Randomised, Controlled Trial of GOLimumab and Methotrexate Versus Methotrexate in Early Diagnosed Psoriatic Arthritis Using Clinical and Whole Body MRI Outcomes. BioMed Central, 2017.

MLA (9th ed.) Citation

De Marco, G., et al. The GOLMePsA Study Protocol: An Investigator-initiated, Double-blind, Parallel-group, Randomised, Controlled Trial of GOLimumab and Methotrexate Versus Methotrexate in Early Diagnosed Psoriatic Arthritis Using Clinical and Whole Body MRI Outcomes. BioMed Central, 2017.